Skip to content
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe
06Oct2025
  • Home
  • About
  • News
  • Subscribe
06Oct2025
Cost Curve NewsCost Curve News
Cost Curve News

Pharm-to-Table Commentary on Earnings Calls: So Hot Right Now

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
2 months ago
Keep Reading
Cost Curve News

A Skyrocketing Number of Big City Hospitals Are Qualifying as ‘Administratively Rural’

INFLECTION POINT/ Health Affairs Analysis Shows That Urban Hospitals Are Increasingly Able to Grab Benefits Intended for Rural Facilities All hospitals are not alike. Some are big. Some are small.
2 months ago
Keep Reading
Cost Curve News

A Skyrocketing Number of Big City Hospitals Are Qualifying as ‘Administratively Rural’

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
2 months ago
Keep Reading
Cost Curve News

What the Heck Was STAT Driving At With Its Ham-Handed Attempted Takedown of Transparency Reports?

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
2 months ago
Keep Reading
Cost Curve News

MFN Comes Roaring Back as Trump Sends Letters Pushing 17 Companies to Offer MFN Prices

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
2 months ago
Keep Reading
Cost Curve News

The Government Has Green-Lit a Major Change to 340B Payments … With Some Limits

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
2 months ago
Keep Reading
Cost Curve News

AstraZeneca ‘Absolutely Considering’ Pharm-to-Table

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
2 months ago
Keep Reading
Cost Curve News

Drugs From Europe Will Be Hit With a 15% Tariff, But Key Details Are Still Cloudy

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
2 months ago
Keep Reading
Cost Curve News

RFK Jr. Takes Aim at the Preventive Services Task Force, Injecting More Uncertainty into Public Health

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
2 months ago
Keep Reading
Cost Curve News

A USC Analysis Tallies the Potential Savings Associated with ‘Delinking’ Middleman Comp from List Prices

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
2 months ago
Keep Reading
456

Latest Posts

Putting All of the Pharm-to-Table Resources in One Place

October 3, 2025

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

October 2, 2025

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

October 1, 2025

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

September 30, 2025

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

September 29, 2025

Popular

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Tariffs and MFN Dominate the Headlines, But Details Remain Scant

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (2,632)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (1,696)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (1,607)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,489)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,471)

Your trusted source for daily updates on drug pricing and policy. Stay informed and ahead of the curve with Cost Curve News.

Latest News

Putting All of the Pharm-to-Table Resources in One Place

October 3, 2025

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

October 2, 2025

Subcribe To Newsletter

Subscribe to our newsletter and stay informed about new posts and stay up-to-date on the latest news
Subscribe
© 2025 Cost Curve News | All Rights Reserved
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe